{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:04:56Z","timestamp":1791864296962,"version":"4.3.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1111\/j.1574-695x.2006.00047.x","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T10:49:34Z","timestamp":1139395774000},"page":"386-392","source":"Crossref","is-referenced-by-count":7,"title":["Safety and preliminary immunogenicity of MenC\/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier"],"prefix":"10.1093","volume":"46","author":[{"given":"Antonio E.","family":"P\u00c3\u00a9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00c3\u00a9lix O.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Banderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Llanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daymi","family":"Guzm\u00c3\u00a1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"D\u00c3\u00adaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00c3\u00ada","family":"Guirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Canaan-Haden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Guill\u00c3\u00a9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB28","unstructured":"\u00c3\u0081lvarez A , Mart\u00c3\u00adn A , Falc\u00c3\u00b3n V , de la Rosa MC , Gonz\u00c3\u00a1lez S , Guill\u00c3\u00a9n G & Silva R (2004) Association of the P64k dihydrolipoamide dehydrogenase to the Neisseria meningitidis membrane. Biotecnol Apl 21: 147\u00e2\u0080\u0093152."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB31","unstructured":"Almeyda L & Rico O (1994) General information about meningococcal disease. Vaccine for the prevention. Rev Hosp Ni\u00c3\u00b1os Buenos Aires 36: 234\u00e2\u0080\u0093241."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB36","doi-asserted-by":"crossref","unstructured":"Alving CR , Glass M & Detrick B (1992) Summary: Adjuvants\/Clinical Trials Working Group. AIDS Res Hum Retroviruses 8: 1427\u00e2\u0080\u00931430.","DOI":"10.1089\/aid.1992.8.1427"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB38","unstructured":"Anderson EL , Bowers T , Mink CM , et al. (1994) Safety and immunogenicity of meningococcal A and C polysaccharide conjugated vaccine in adults. Infect Immun 62: 3391\u00e2\u0080\u00933395."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB41","doi-asserted-by":"crossref","unstructured":"Andrews N , Borrow R & Miller E (2003) Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin Diagn Lab Immunol 10: 780\u00e2\u0080\u0093786.","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB27","unstructured":"Bringas R & Fernandez JA (1995) Lipoamide dehydrogenase from Neisseria meningitidis has a lipoyl domain. Proteins 21: 303\u00e2\u0080\u0093306."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB8","doi-asserted-by":"crossref","unstructured":"Cadoz M , Armand J , Arminjon F , Gire R & Lafaix C (1985) Tetravalent (A, C, Y, W 135) meningococcal vaccine in children: immunogenicity and safety. Vaccine 3: 340\u00e2\u0080\u0093342.","DOI":"10.1016\/S0264-410X(85)90266-X"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB26","doi-asserted-by":"crossref","unstructured":"Carmenate T , Canaan L , Alvarez A , et al. (2004) Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide\u00e2\u0080\u0093P64k protein conjugates. FEMS Immunol Med Microbiol 40: 193\u00e2\u0080\u0093199.","DOI":"10.1016\/S0928-8244(03)00346-8"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB15","doi-asserted-by":"crossref","unstructured":"Fattom A , Cho YH , Chu C , Fuller S , Fries L & Naso R (1999) Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine 17: 126\u00e2\u0080\u0093133.","DOI":"10.1016\/S0264-410X(98)00162-5"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB4","first-page":"245","volume-title":"Meningococcal Disease","author":"Frasch","year":"1995"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB2","unstructured":"Gaspar M , Leite F , Brumana L , F\u00c3\u00a9lix B & Stella AA (2001) Epidemiology of meningococcal meningitis in Angola, 1994\u00e2\u0080\u00932000. Epidemiol Infect 127: 421\u00e2\u0080\u0093424."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB33","unstructured":"Gheesling LL , Carlone GM , Pais LB , et al. (1994) Multicentre comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 32: 1475\u00e2\u0080\u00931482."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB6","unstructured":"Goldsneichder I , Gotschlich E & Artenstein MS (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129: 1307\u00e2\u0080\u00931326."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB43","doi-asserted-by":"crossref","unstructured":"Gonzalez G , Crombet T , Catala M , Mirabal V , Hernandez JC , Gonzalez Y , Marinello P , Guillen G & Lage A (1998) A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial. Annals of Oncology 9: 431\u00e2\u0080\u0093435.","DOI":"10.1023\/A:1008261031034"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB21","doi-asserted-by":"crossref","unstructured":"Gonzalez S , Vina L , Nazabal C , Chinea G , Caballero E & Musacchio A (2000) B-cell epitope mapping of the Neisseria meningitidis P64k protein using overlapping peptides. Biotechnol Appl Biochem 32 (Part 1) 1\u00e2\u0080\u00938.","DOI":"10.1042\/BA19990115"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB25","unstructured":"Gonz\u00c3\u00a1lez G , Pardo OL , S\u00c3\u00a1nchez B , et al. (1997) Induction of immune recognition of self-epidermal growth factor II: characterization of the antibody response and the use of a fusion protein. Vaccine Res 6: 91\u00e2\u0080\u0093100."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB23","unstructured":"Gonz\u00c3\u00a1lez S , Alvarez A , Caballero E , Vina L , Guill\u00c3\u00a9n G & Silva R (2000) P64k meningococcal protein as immunological carrier for weak immunogens. Scand J Immunol 52: 113\u00e2\u0080\u0093116."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB18","unstructured":"Guill\u00c3\u00a9n G , Alvarez A , Silva R , et al. (1998) Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis. Biotechnol Appl Biochem 27: 189\u00e2\u0080\u0093196."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB24","unstructured":"Guill\u00c3\u00a9n G , Duarte C , Alvarez A , et al. (1997) System for the expression of heterologous antigens as fusion proteins. Patent WO9726359."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB5","doi-asserted-by":"crossref","unstructured":"Jodar L , Feavers IM , Salisbury D & Granoff DM (2002) Development of vaccines against meningococcal disease. Lancet 359: 1499\u00e2\u0080\u00931508.","DOI":"10.1016\/S0140-6736(02)08416-7"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB10","unstructured":"Lesinski GB & Westerink MA (2001) Novel vaccine strategies to T-independent antigens. J Microbiol Methods 47: 135\u00e2\u0080\u0093149."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB14","doi-asserted-by":"crossref","unstructured":"Lindberg AA (1999) Glycoprotein conjugate vaccines. Vaccine 17 (Suppl 2) S28\u00e2\u0080\u0093S36.","DOI":"10.1016\/S0264-410X(99)00232-7"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB34","unstructured":"Maslanka SE , Gheesling LL , Libutti DE , et al. (1997) Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The multilaboratory study group. Clin Diagn Lab Immunol 4: 156\u00e2\u0080\u0093167."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB40","doi-asserted-by":"crossref","unstructured":"McLennan J , Shackley F , Heath P , et al. (2000) Safety, immunogenicity and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial. JAMA 283: 2795\u00e2\u0080\u00932801.","DOI":"10.1001\/jama.283.21.2795"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB30","unstructured":"P\u00c3\u00a9rez A , Dickinson F , Baly A & Mart\u00c3\u00adnez R (1999) The epidemiological impact of antimeningococcal B vaccination in Cuba. Mem Inst Oswaldo Cruz 94: 433\u00e2\u0080\u0093440."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB35","unstructured":"P\u00c3\u00a9rez A , Dickinson F , Cinza Z , et al. (2001) Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers. Biotechnol Appl Biochem 34: 121\u00e2\u0080\u0093125."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB9","doi-asserted-by":"crossref","unstructured":"Peltola H (1999) Prophylaxis of bacterial meningitis. Infect Clin N Am 13: 685\u00e2\u0080\u0093710.","DOI":"10.1016\/S0891-5520(05)70101-X"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB11","doi-asserted-by":"crossref","unstructured":"Ramsay MA , Andrews N , Kaczmarski EB & Miller E (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357: 195\u00e2\u0080\u0093196.","DOI":"10.1016\/S0140-6736(00)03594-7"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB12","doi-asserted-by":"crossref","unstructured":"Richmond P , Borrow R , Miller E , et al. (1999a) Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and prime for memory. J Infect Dis 179: 1569\u00e2\u0080\u00931572.","DOI":"10.1086\/314753"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB37","doi-asserted-by":"crossref","unstructured":"Richmond P , Borrow R , Miller E , et al. (1999b) Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and prime for memory. J Infect Dis 179: 1569\u00e2\u0080\u00931572.","DOI":"10.1086\/314753"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB39","doi-asserted-by":"crossref","unstructured":"Richmond P , Goldblatt JF , Fusco PC , et al. (1999c) Safety and immunogenicity of a new Neisseria meningitidis serogroup C\u00e2\u0080\u0093tetanus toxoid conjugated vaccine in healthy adults. Vaccine 18: 641\u00e2\u0080\u0093646.","DOI":"10.1016\/S0264-410X(99)00276-5"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB13","doi-asserted-by":"crossref","unstructured":"Richmond P , Borrow R , Findlow J , et al. (2001) Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains. Infect Immun 69: 2378\u00e2\u0080\u00932382.","DOI":"10.1128\/IAI.69.4.2378-2382.2001"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB1","unstructured":"S\u00c3\u00a1ez-Llorens X & McCracken GH (2003) Bacterial meningitis. Lancet 361: 2139\u00e2\u0080\u00932148."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB16","doi-asserted-by":"crossref","unstructured":"Schutze MP , Leclerc C , Jolivet M , Audibert F & Chedid L (1985) Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol 135: 2319\u00e2\u0080\u00932322.","DOI":"10.4049\/jimmunol.135.4.2319"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB20","unstructured":"Sierra GV , Campa HC , Varc\u00c3\u00a1rcel NM , et al. (1991) Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann 14: 195\u00e2\u0080\u0093207; discussion 208-10."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB19","doi-asserted-by":"crossref","unstructured":"Li de la Sierra I , Pernot L , Prange T , et al. (1997a) Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis. J Mol Biol 269: 129\u00e2\u0080\u0093141.","DOI":"10.1006\/jmbi.1997.1009"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB29","doi-asserted-by":"crossref","unstructured":"Li de la Sierra I , Pernot L , Prang\u00c3\u00a9 T , Saludjian P , Schiltz M , Fourme R & Padr\u00c3\u00b3n G (1997b) Molecular structure of the lipoamide dehydrogenase domain of a surface antigen from Neisseria meningitidis. J Mol Biol 269: 129\u00e2\u0080\u0093141.","DOI":"10.1006\/jmbi.1997.1009"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB17","unstructured":"Silva R , Selman HM , Guill\u00c3\u00a9n G et al. (1994) Nucleotide sequence coding for an outer membrane protein from Neisseria meningitidis and use of said protein in vaccine preparations. US Patent 5,286,484."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB22","unstructured":"Silva R , Men\u00c3\u00a9ndez T , Alonso LM , et al. (1999) Characterisation of the lpdA gene from Neisseria meningitidis by polymerase chain reaction, restriction fragment length polymorphism and sequencing. FEMS Microbiol Lett 174: 191\u00e2\u0080\u009399."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB42","doi-asserted-by":"crossref","unstructured":"Trotter CL , Andrews NJ , Kaczmarski EB , Miller E & Ramsay ME (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364: 365\u00e2\u0080\u0093367.","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB7","doi-asserted-by":"crossref","unstructured":"Vodopija I , Baklaic Z , Hauser P , Roelants P , Andre FE & Safary A (1983) Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide. Infect Immun 42: 599\u00e2\u0080\u0093604.","DOI":"10.1128\/IAI.42.2.599-604.1983"},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB32","unstructured":"WHO. (1995) The use of essential drugs. Sixth report of the WHO Expert Committee. World Health Organ Tech Rep Ser 850: 1\u00e2\u0080\u0093137."},{"key":"10.1111\/j.1574-695X.2006.00047.x-BIB3","volume-title":"Control of Epidemic Meningococcal Disease. WHO Practical Guidelines","author":"WHO","year":"1998"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/46\/3\/386\/19168776\/46-3-386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T12:08:21Z","timestamp":1683374901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2006.00047.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2006.00047.x","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}